Royalty Pharma plc vs Novartis AG
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Royalty Pharma plc currently has the stronger revenue growth signal.
Royalty Pharma plc and Novartis AG show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Royalty Pharma plc | Novartis AG |
|---|---|---|
| Current Price | ₹54.48 | ₹151.4 |
| Market Cap | ₹31,371.34 Cr. | ₹2.89 L Cr. |
| Industry | Pharmaceuticals | Pharmaceuticals |
| P/E Ratio | 28.347368 | 21.604586 |
| ROE (%) | — | — |
| Debt/Equity | — | — |
| Sales Growth 5Y (%) | — | — |
| Profit Growth 5Y (%) | — | — |
| Promoter Holding (%) | — | — |
| Revenue Rank | Rank 3 | Rank 4 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |